AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and market outlook.

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on TEM stock.

Tempus AI TEM, an innovator in artificial intelligence ... outperforming the 16.5% rise of the Medical Info Systems industry and the benchmark’s 6.8% increase. In the meantime, the Medical ...

In the fourth quarter of 2024, Tempus AI posted 35.8% year-over-year revenue growth driven by strong 30.6% year-over-year sales growth in Genomics with unit growth of 22.5%. Data and services too ...

CompanyOverview\|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Genomics grew 30.6% year-over-year to $120.4 million and unit growth came in at 22.5% year-over-year. Tempus AI said it ended the quarter with $940 million in total remaining contract value and ...

Genomics revenue grew 30.6% year-over-year to $120.4 million and unit growth came in at 22.5%. Tempus AI ended the quarter with $940 million in total remaining contract value and 140% net revenue ...